Authors:
FRIEDRICH M
HENZE M
DOCKE W
GELLRICH S
VOLK HD
STERRY W
ASADULLAH K
Citation: M. Friedrich et al., CHARACTERIZATION OF CUTANEOUS LYMPHOCYTES - POSSIBILITIES AND LIMITS, Journal of investigative dermatology, 110(4), 1998, pp. 586-586
Citation: U. Settmacher et al., OPTIMIZATION OF IMMUNOSUPPRESSIVE THERAPY BY MONITORING OF IMMUNE FUNCTION IN TRANSPLANT RECIPIENTS, CLINICAL IMMUNOTHERAPEUTICS, 3(5), 1995, pp. 386-394
Authors:
VONZGLINICKI T
SARETZKI G
DOCKE W
LOTZE C
Citation: T. Vonzglinicki et al., MILD HYPEROXIA SHORTENS TELOMERES AND INHIBITS PROLIFERATION OF FIBROBLASTS - A MODEL FOR SENESCENCE, Experimental cell research, 220(1), 1995, pp. 186-193
Authors:
BOHN J
NIEMANN B
ROGGENBUCK D
DOCKE W
JAHN S
Citation: J. Bohn et al., TUMOR-CELL BINDING BY A HUMAN MONOCLONAL IGM ANTIBODY FROM THE SPLEENOF A NON-TUMOR-ASSOCIATED PATIENT IS DUE TO SOMATIC MUTATIONS IN THE V-H GENE, Clinical and experimental immunology, 99(3), 1995, pp. 376-383
Authors:
BOHME H
SEIFERT M
ROGGENBUCK D
DOCKE W
VONBAEHR R
HANSEN A
Citation: H. Bohme et al., CHARACTERIZATION OF A B-CLL DERIVED IGM-LAMBDA ANTIBODY EXPRESSING TYPICAL FEATURES OF A NPAB, Immunology letters, 41(2-3), 1994, pp. 261-266
Authors:
BOHN J
ROGGENBUCK D
SETTMACHER U
DOCKE W
VOLK HD
VONBAEHR R
JAHN S
Citation: J. Bohn et al., BINDING OF NATURAL HUMAN-IGM AUTOANTIBODIES TO HUMAN TUMOR-CELL LINESAND STIMULATED NORMAL T-LYMPHOCYTES, Immunology letters, 39(2), 1994, pp. 187-194